Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance in The Patients Treated With Primary PCI for STEMI

NCT00697021 is registered in ClinicalTrials.gov with Assaf-Harofeh Medical Center as lead sponsor.

NCT NCT00697021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00697021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance in The Patients Treated With Primary PCI for STEMI
Lead sponsor
Assaf-Harofeh Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2008
Completion date
October 31, 2009
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute st segment elevation myocardial infarction